greeksoup/ stock research

Intuitive Surgical (ISRG) FY2023 results: revenue $7.1 billion, up 14.5% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $7.1 billion for fiscal 2023, the year ended 31 December 2023, up 14.5% on the year before. Net income was $1.8 billion, up 36.0%, and diluted earnings per share $5.03. The figures are the company's own, from the 10-K it filed with the SEC on 31 January 2024.

Revenue
$7.1 billion
+14.5% on the year
FY2016FY2023
Operating margin
24.8%
25.3% a year earlier
FY2016FY2023
Net income
$1.8 billion
+36.0% on the year
FY2016FY2023
Diluted EPS
$5.03
+37.8% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue7,1246,2225,710+14.5%
Cost of revenue2,3952,0261,752+18.2%
Gross profit4,7304,1963,958+12.7%
Gross margin66.4%67.4%69.3%
Research and development999879671+13.6%
Selling, general and administrative1,9641,7401,466+12.9%
Operating income1,7671,5771,821+12.0%
Operating margin24.8%25.3%31.9%
Pre-tax income1,9591,6071,890+21.9%
Income tax142262162-46.0%
Effective tax rate7.2%16.3%8.6%
Net income1,7981,3221,705+36.0%
Net margin25.2%21.3%29.9%
Diluted EPS$5.03$3.65$4.66+37.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow1,8141,4912,089+21.7%
Capital expenditure1,064532340+99.9%
Free cash flow7509581,750-21.8%
Free cash flow margin10.5%15.4%30.6%
Cash from investing-3601,371-2,462
Cash from financing-288-2,57243.0
Depreciation and amortisation402354307+13.7%
Share-based compensation593513449+15.5%
Buybacks4162,6070.0-84.0%
Diluted shares, weighted357m362m366m-1.3%
Shares outstanding at period end352m350m358m+0.7%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity13,30811,04211,901+20.5%
Non-controlling interest89.770.750.4+26.9%
Debt0.00.00.0
Operating lease liabilities64.569.666.6-7.3%
Other liabilities1,9801,7921,537+10.5%
Total liabilities and equity15,44212,97413,555+19.0%
Fixed assets3,5382,3741,876+49.0%
Goodwill349348344+0.1%
Intangible assets39.149.870.5-21.5%
Investments4,5935,1607,329-11.0%
Cash and equivalents2,7501,5811,291+73.9%
Receivables1,130942783+20.0%
Inventory1,221893587+36.7%
Other assets1,8221,6251,275+12.1%
Total assets15,44212,97413,555+19.0%

10-K for the year ended 31 December 2023, filed 31 January 2024: the filing.